Machine learning-driven estimation of mutational burden highlights DNAH5 as a prognostic marker in colorectal cancer
Abstract Background Tumor Mutational Burden (TMB) have emerged as pivotal predictive biomarkers in determining prognosis and response to immunotherapy in colorectal cancer (CRC) patients. While Whole Exome Sequencing (WES) stands as the gold standard for TMB assessment, carry substantial costs and d...
| Published in: | Biology Direct |
|---|---|
| Main Authors: | , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-11-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13062-024-00564-0 |
